
Coverage is under constant review and is subject to change.
Access to a generic or biosimilar equivalent is generally reported to be identical to that of the relevant brand name medication.
|
TYPE OF LISTING |
ONTARIO COVERAGE |
||
|
Bisphosphonates |
Etidronate |
Didronel; Generics Available |
Not in Drug Formulary |
|
Alendronate |
Fosamax; Generics Available |
Regular Benefit (10mg Generics, 70mg Generics); Limited Coverage (Fosamax 70 mg);
|
|
|
Fosavance; Generics Available |
Regular Benefit (Generics); |
||
|
Risedronate |
Actonel; Generics Available |
Regular Benefit (5mg Generics, All 30mg, All 35mg, All 150mg); Limited Coverage (Actonel 150mg); |
|
|
Actonel; DR |
Regular Benefit (Generics); |
||
|
Zoledronic Acid |
Aclasta; Generics Available |
Regular Benefit (4mg inj Generics except Zometa Concentrate); |
|
|
SERMs |
Raloxifene |
Evista; Generics Available |
Limited Coverage |
|
Teriparatide (PTH) |
Forteo; Generics Available |
Limited Coverage |
|
|
Osnuvo (biosimilar) |
Limited Coverage |
||
|
Denosumab |
Prolia |
Limited Coverage |
|
|
Jubbonti (biosimilar) |
Limited Coverage |
||
|
Stoboclo (biosimilar) |
Limited Coverage |
||
|
Osenvelt (biosimilar) |
Limited Coverage |
||
|
Romosozumab |
Evenity |
Limited Coverage |
|